Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Girls with prepubertal simple hypertrichosis have higher dihydrotestosterone (DHT) levels.

Hirsutism, often caused by PCOS, is treated with medication and weight loss is important for obese women with PCOS.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

A postmenopausal woman had rare symptoms due to a possible ovarian tumor, needing thorough evaluation.

High androgen levels often cause female hirsutism and infertility.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

A rare ovarian tumor caused high testosterone, hair loss, and missed periods, but surgery fixed these issues and led to pregnancy.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.

A man developed hair loss from testosterone treatment but improved with additional medication.

Elderly patients with frailty should be checked for hypopituitarism, as treatment can greatly improve their health and lifespan.

3βHSD2 is not useful for diagnosing PCOS.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

21-hydroxylase deficiency causes hormone imbalances leading to various symptoms, and diagnosis involves clinical and genetic tests.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Diagnosing simple-virilizing congenital adrenal hyperplasia can be difficult and requires thorough testing and expert advice.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Growth hormone therapy boosts androgen effects on skin in men.

Oestrogen does not affect adrenal androgen levels in children and adolescents.